Israelsen, M., Francque, S., Tsochatzis, E. A. & Krag, A. Steatotic liver disease. Lancet 404, 1761–1778 (2024).

Article  CAS  PubMed  Google Scholar 

Liebe, R. et al. Diagnosis and management of secondary causes of steatohepatitis. J. Hepatol. 74, 1455–1471 (2021).

Article  CAS  PubMed  Google Scholar 

Wong, V. W., Ekstedt, M., Wong, G. L. & Hagstrom, H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J. Hepatol. 79, 842–852 (2023).

Article  PubMed  Google Scholar 

Reggidori, N. et al. Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs. JHEP Rep. 5, 100784 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Moeini, A. et al. Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity. J. Hepatol. 66, 952–961 (2017).

Article  CAS  PubMed  Google Scholar 

Loomba, R. et al. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin. Gastroenterol. Hepatol. 8, 891–898 (2010).

Article  PubMed  Google Scholar 

Babuta, M. et al. A novel experimental model of MetALD in male mice recapitulates key features of severe alcohol-associated hepatitis. Hepatol. Commun. 8, e0450 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966–1986 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537–2564 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O. & Heikenwalder, M. From NASH to HCC: current concepts and future challenges. Nat. Rev. Gastroenterol. Hepatol. 16, 411–428 (2019).

Article  PubMed  Google Scholar 

Gallage, S. et al. The therapeutic landscape of hepatocellular carcinoma. Med 2, 505–552 (2021).

Article  CAS  PubMed  Google Scholar 

Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Rev. Gastroenterol. Hepatol. 10, 686–690 (2013).

Article  CAS  PubMed  Google Scholar 

Gonzalez-Palacios, S. et al. Increased ultra-processed food consumption is associated with worsening of cardiometabolic risk factors in adults with metabolic syndrome: longitudinal analysis from a randomized trial. Atherosclerosis 377, 12–23 (2023).

Article  CAS  PubMed  Google Scholar 

Bataller, R., Arab, J. P. & Shah, V. H. Alcohol-associated hepatitis. N. Engl. J. Med. 387, 2436–2448 (2022).

Article  CAS  PubMed  Google Scholar 

Marra, F. & Svegliati-Baroni, G. Lipotoxicity and the gut-liver axis in NASH pathogenesis. J. Hepatol. 68, 280–295 (2018).

Article  CAS  PubMed  Google Scholar 

Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E. & Heikenwalder, M. The immunology of hepatocellular carcinoma. Nat. Immunol. 19, 222–232 (2018).

Article  CAS  PubMed  Google Scholar 

Llovet, J. M. et al. Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat. Rev. Gastroenterol. Hepatol. 20, 487–503 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vujkovic, M. et al. A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation. Nat. Genet. 54, 761 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwantes-An, T. H. et al. Genome-wide association study and meta-analysis on alcohol-associated liver cirrhosis identifies genetic risk factors. Hepatology 73, 1920–1931 (2021).

Article  CAS  PubMed  Google Scholar 

Ogrodnik, M. et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 8, 15691 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samuel, V. T. et al. Inhibition of protein kinase Cε prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117, 739–745 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henao-Mejia, J. et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179–185 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pfister, D. et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592, 450–456 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumar, R., Goh, B.-B. G., Kam, J. W., Chang, P. E. & Tan, C. K. Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma. Clin. Mol. Hepatol. 26, 196–208 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Li, M. et al. Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma. Hepatology 79, 560–574 (2024).

Article  PubMed  Google Scholar 

Lemaitre, L. et al. Spatial analysis reveals targetable macrophage-mediated mechanisms of immune evasion in hepatocellular carcinoma minimal residual disease. Nat. Cancer 5, 1534–1556 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li, X. et al. Activated ATF6α is a hepatic tumour driver restricting immunosurveillance. Nature 651, 796–807 (2026).

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Lorenzo, S. et al. Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role. Cancers 12, 3182 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Kotsiliti, E. et al. Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling. J. Hepatol. 79, 296–313 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Llovet, J. M. & Heikenwalder, M. Atezolizumab plus bevacizumab in advanced HCC: efficacy in NASH-specific etiology. Gastroenterology 165, 1308–1310 (2023).

Article  CAS  PubMed  Google Scholar 

Schieber, K. et al. Self-reports on symptoms of alcohol abuse: liver transplant patients versus rehabilitation therapy patients. Prog. Transpl. 25, 203–209 (2015).

Article  Google Scholar 

Staufer, K. et al. Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver disease. J. Hepatol. 77, 918–930 (2022).